コンテンツへスキップ
Merck
すべての画像(2)

資料

B4932

Sigma-Aldrich

Butyl-γ-cyclodextrin

ログイン組織・契約価格を表示する
すべての画像(2)

About This Item

MDL番号:
MFCD03452848
UNSPSCコード:
12352201
PubChem Substance ID:
329773246
NACRES:
NA.25

形状

solid

保管温度

2-8°C

SMILES記法

CCCCOC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3CO)O[C@H]4[C@H](O)[C@@H](O)[C@H](O[C@@H]4CO)O[C@H]5[C@H](O)[C@@H](O)[C@H](O[C@@H]5CO)O[C@H]6[C@H](O)[C@@H](O)[C@H](O[C@@H]6CO)O[C@H]7[C@H](O)[C@@H](O)[C@H](O[C@@H]7CO)O[C@H]8[C@H](O)[C@@H](O)[C@H](O[C@@H]8CO)O[C@H]9[C@H](O)[C@@H](O)[C@H](O[C@@H]9CO)O[C@H]1[C@H](O)[C@H]2O

InChI

1S/C52H88O40/c1-2-3-4-76-12-20-44-28(67)36(75)52(84-20)91-43-19(11-59)82-50(34(73)26(43)65)89-41-17(9-57)80-48(32(71)24(41)63)87-39-15(7-55)78-46(30(69)22(39)61)85-37-13(5-53)77-45(29(68)21(37)60)86-38-14(6-54)79-47(31(70)23(38)62)88-40-16(8-56)81-49(33(72)25(40)64)90-42-18(10-58)83-51(92-44)35(74)27(42)66/h13-75H,2-12H2,1H3/t13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-/m1/s1

InChI Key

GKKAPJLYIDRKJM-CEIOSFLZSA-N

その他情報

To gain a comprehensive understanding of our extensive range of Oligosaccharides for your research, we encourage you to visit our Carbohydrates Category page.

保管分類コード

11 - Combustible Solids

WGK

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable

個人用保護具 (PPE)

Eyeshields, Gloves, type N95 (US)

試験成績書（COA）

製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

J Hu et al.
Methods and findings in experimental and clinical pharmacology, 31(7), 449-456 (2009-11-13)
Owing to their bioadaptability and multifunctional characteristics, cyclodextrins have been shown to be useful in drug delivery systems. This article presents the unique structure and properties and the current application of natural and chemically modified cyclodextrins in transdermal drug delivery
Kaneto Uekama
Chemical & pharmaceutical bulletin, 52(8), 900-915 (2004-08-12)
The pharmaceutically useful cyclodextrins (CyDs) are classified into hydrophilic, hydrophobic, and ionic derivatives. Because of the multi-functional characteristics and bioadaptability, these CyDs are capable of alleviating the undesirable properties of drug molecules through the formation of inclusion complexes or the
Birna S Gudmundsdottir et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 30(1), 35-41 (2013-11-12)
To test a new drug delivery platform with dorzolamide γ-cyclodextrin (γCD) nanoparticle eye drops for intraocular pressure (IOP) control and safety and compare with Trusopt.(®) Self-aggregating γCD nanoparticle eye drops containing 3% dorzolamide were given once a day (QD) and
Gauti Jóhannesson et al.
Acta ophthalmologica, 92(6), 550-556 (2014-01-01)
We have developed nanoparticle γ-cyclodextrin dexamethasone (DexNP) and dorzolamide (DorzNP) eye drops that provide sustained high drug concentrations on the eye surface. To test these characteristics, we measured dexamethasone and dorzolamide levels in tear fluid in humans following eye drop
Prosenjit Bhattacharya et al.
Journal of fluorescence, 24(3), 719-725 (2013-12-18)
This paper reports the double confinement of 4,4-diaminodiphenyl sulfone (Dapsone) inside γ-cyclodextrin (CD) in presence of surfactants (cationic, anionic and nonionic) using steady-state and time-resolved fluorescence spectroscopy. Interpretation of fluorescence spectra, fluorescence anisotropy and time resolved fluorescence decay of the
関連する文献をすべて表示

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら（テクニカルサービス）